Magnetic Resonance Imaging as a Predictor of Pathologic Response in Patients Treated With Neoadjuvant Systemic Treatment for Operable Breast Cancer: Translational Breast Cancer Research Consortium Trial 017 De Los Santos JF, Cantor A, Amos KD, et al (Univ of Alabama at Birmingham Comprehensive Cancer Ctr; Univ of North Carolina Chapel Hill; et al) Cancer 119:1776-1783, 2013§
